Wheeler 2007 Milk Immmune Factors

Download as pdf or txt
Download as pdf or txt
You are on page 1of 12

See

discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/5855229

Immune Components of Colostrum and Milk—


A Historical Perspective

Article in Journal of Mammary Gland Biology and Neoplasia · January 2008


Impact Factor: 4.53 · DOI: 10.1007/s10911-007-9051-7 · Source: PubMed

CITATIONS READS

56 37

4 authors, including:

Thomas T Wheeler Colin Prosser


AgResearch Dairy Goat Co-operative (N.Z.) Ltd
68 PUBLICATIONS 1,892 CITATIONS 97 PUBLICATIONS 1,950 CITATIONS

SEE PROFILE SEE PROFILE

All in-text references underlined in blue are linked to publications on ResearchGate, Available from: Colin Prosser
letting you access and read them immediately. Retrieved on: 03 July 2016
J Mammary Gland Biol Neoplasia
DOI 10.1007/s10911-007-9051-7

Immune Components of Colostrum


and Milk—A Historical Perspective
Thomas T. Wheeler & Alison J. Hodgkinson &
Colin G. Prosser & Stephen R. Davis

Received: 2 October 2007 / Accepted: 12 October 2007


# Springer Science + Business Media, LLC 2007

Abstract Key developments in the understanding of the Introduction


immune functions of milk and colostrum are reviewed,
focusing on their proteinaceous components. The topics The concept that milk, mammary secretions and the
covered include the immunoglobulins, immune cells, mammary gland have major roles in immune defense is
immunomodulatory substances, and antimicrobial proteins. an old one. The bactericidal property of milk was recorded
The contributions of new technologies and the introduction in the scientific literature in the late nineteenth century [1,
of fresh approaches from other fields are highlighted, as are 2]. Moreover, observations at this time on the ability of
the contributions that mammary biology research has made milk to provide immunity to the newborn [3] played a key
to the development of other fields. Finally, a summary of role in the development of modern immunology. The aim of
some current outstanding questions and likely future this review is to provide a modern audience with a timeline
directions of the field are given. for the key discoveries in milk immunology, illustrating
how the current understanding of the immune function of
Keywords Lactation . Mammary . Antimicrobial milk evolved, and to offer some pointers for the future
direction of the field.
Abbreviations This review is divided into three sections: the immuno-
BPI bactericidal/permeability increasing protein globulins and immune cells, immunomodulatory compo-
DHA docosahexaenoic acids nents, and antimicrobial components, covering elements of
EPA eicosapentaenoic acid both innate and adaptive immunity, immune defenses in the
IgA immunoglobulin A mammary gland and the participation of the mammary
IgG immunoglobulin G gland in the mucosal defense system. In this we focus
LBP lipopolysaccharide binding protein largely on the proteinaceous components of milk, some of
LC-PUFA long chain-polyunsaturated fatty acids which are depicted in Fig. 1. Reviews describing physical
barriers, the role of probiotics, and the carbohydrate and
lipid components of milk that have host defense functions
T. T. Wheeler (*) : A. J. Hodgkinson
Dairy Science and Technologies Section,
have recently been presented elsewhere [4, 5].
AgResearch, Ruakura Research Centre,
Private Bag 3123,
Hamilton, New Zealand Immunoglobulins in Milk
e-mail: [email protected]

C. G. Prosser Today it is largely forgotten that the immune properties of


Dairy Goat Co-operative (NZ) Ltd., milk helped lay the foundation of modern immunology. In
Hamilton, New Zealand 1892, Paul Ehrlich demonstrated that mice immunized
S. R. Davis
against plant toxins passed immunity to the fetus in utero as
Vialactia Biosciences Ltd., well as via the milk. These observations were subsequently
P. O. Box 109-185, Newmarket, Auckland, New Zealand shown to be due to an ammonium sulfate precipitable
J Mammary Gland Biol Neoplasia

blood IgG (substances causing agglutination of cells) in the blood,


IgA
basolateral derived from the mother’s milk [11].
membrane It was appreciated early on that there were significant
Immune cells
differences between mammals in the immunological func-
tion of the mammary gland. For example, it was noted that
colostrum was important for immune transfer to the newborn
only in mammals with multi-layered placentae (for example
mammary
epithelial cell the ungulates) [12–14]. In these species, the antibodies were
shown to be absorbed into the bloodstream via the neonatal
IgG sIgA proteases intestinal mucosa in the first 24–48 h of life [15]. Thus, by
complement lactoferrin 1930, the role of the mammary gland in conferring
cytokines antimicrobial acute phase protection to the neonate through the accumulation and
peptides proteins
secretion of agglutinating antibodies directed against
lysozyme, oxidases,
alveolar lumen peroxidases pathogens was firmly established.
Fig. 1 Schematic showing some of the principal known proteinaceous The bivalent structure of antibodies and the nature of
components of the host defense system in milk and colostrum. their interaction with antigens were gradually elucidated
through the 1940s. The highly specific nature of the
substance, termed an antibody [6]. Ehrlich extended this antibodies in mammary secretions was demonstrated
work to develop the concept of passive and active through analysis of the antibodies in colostrum fed to
immunisation via antibodies, for which he was awarded calves that had died from infections with different strains of
the Nobel Prize in 1908. Many other researchers made E. coli [16]. While the presence of antibodies in milk and
important contributions through this early period (see colostrum was indisputable, at this time there was still
Campbell and Petersen [7] for an excellent review of the debate over their source and the nature of the therapeutic
history of immune milk). For example, Famulener [8] benefit that could be derived from them [7, 17].
showed that goats immunized prior to parturition could The development of polyacrylamide gel electrophoresis
transmit this immunity to the sera of their offspring via and size-exclusion chromatography by the 1960s greatly
colostrum and that this transfer could also take place if goat accelerated the characterisation of the immune components
serum was fed. Further experiments around this time of milk. These techniques led to the definition of individual
established the concept of passive immunisation through classes of immunoglobulins (i.e. the agglutinating globulins)
the transfer of milk-derived antibodies from the intestinal as well as comparisons between species. Thus, in sheep the
lumen into the bloodstream. Colostrum was shown to predominant antibody in colostrum was shown to be IgG1
contain a greater concentration of antibodies than mature [18], while in humans it was IgA [19]. Moreover,
milk, and the origin of these substances from serum was mammary secretions and serum were shown to have
confirmed [9]. The importance of colostrum in providing distinct immunoglobulin compositions (see Table 1). De-
protection from bacterial infection was shown by Smith and spite much additional data being accumulated, there were
Little [10] who reported that a calf deprived of colostrum still questions about the fundamental reason for the
lacks “something” which allowed intestinal bacteria to difference in milk immunoglobulins between species.
invade the body and multiply in various organs. Allied In the 1960s, Campbell and Petersen [7] were enthusiastic
work showed that this “something” was specific agglutinins advocates for the therapeutic benefits of colostrum and milk

Table 1 Comparison of levels of immunoglobulin in human and cow colostrum, milk and serum.

Species Ig Concentration (g/l) % of total Ig

Colostrum Milk Serum Colostrum Milk Serum

Humana IgG 0.43 0.04 12.10 2.0 3.0 78.0


IgA 17.35 1.00 2.50 90.0 87.0 16.0
IgM 1.59 0.10 0.93 8.0 10.0 6.0
Cowb IgG1 46.40 0.58 11.20 75.5 71.6 47.0
IgG2 2.87 0.06 9.20 4.7 7.4 38.6
IgA 5.36 0.08 0.37 8.8 9.9 1.6
IgM 6.77 0.09 3.05 11.0 11.1 12.8

Ig immunoglobulin, a [20], b [21].


J Mammary Gland Biol Neoplasia

from immunized cows. In particular, and most controver- presence of the prolactin release inhibitor, bromoergocryp-
sially, systemic responses to oral consumption of immune tine, colostrum-like secretion continued post-partum for
milk were claimed, with beneficial effects on symptoms of several days and mammary IgG1 receptor activity was
arthritis and hay fever [7]. This work was commercialized maintained [26]. Addition of prolactin to mammary cells in
by Ralph Stolle, whose company (http://www.smbimilk. culture resulted in down-regulation of the receptor [29].
com) still markets ‘hyperimmune milk’ to the present Thus, it seems that prolactin plays a role in regulating the
day. IgG1 receptor during Stage 2 lactogenesis. However,
The origin of the immunoglobulins in milk was the regulation of the induction of IgG receptor during Stage 1
source of some controversy. Campbell and Petersen lactogenesis remains poorly understood.
believed that the majority of antibodies in bovine mammary Advances in the knowledge of cellular immunity in
secretions were synthesized within the udder. They based mucosal tissues led to greater understanding of the origins
this premise, in part, on their observation that ‘adequate’ of plasma cells in the mammary gland. These cells were
numbers of plasma cells are present in the udder immedi- shown to migrate into the mammary gland from the gut-
ately before parturition [20]. However, later workers found associated lymphoid tissues (GALT) [30]. Adoptive transfer
only low levels of plasma cells [21]. These differences may studies revealed that lymphocytes from the GALT populate
have been due to differences in the health status of the many mucosal effector sites including the mammary gland.
gland between the experiments. Others favoured a humoral The precursors of plasma cells destined to produce IgA
source of the immunoglobulins in colostrum and milk [17], were shown to originate from GALT and traffic into the
based on the observed decrease in serum immunoglobulin mammary gland near the time of parturition as well as in
levels before parturition and a corresponding increase in the middle and late lactation [31]. In the late 1970s the concept
udder [22]. While IgG was shown to be transported to the of the ‘common mucosal immune system’ was proposed
mammary gland from the serum, IgA was found to be [32] in which the antigenic experience at one mucosal
synthesized within the mammary gland by plasma cells surface was deemed to lead to effector responses at a distant
which had migrated into the gland from the gastrointestinal mucosal tissue, a concept that was supported by the
tract (see below). It was found that in species where IgG is discovery of cell surface receptors and cytokines. Thus,
transferred to the foetus prior to birth (e.g. humans), IgA is the idea emerged that cellular immune defense in the
the predominant immunoglobulin in colostrum, whereas in mammary gland is a local feature of an organism-wide
those born with no circulating IgG (e.g. cattle and sheep), integrated system.
IgG is the predominant immunoglobulin in colostrum. A In the mouse, T-cell migration to the mammary gland
10-fold increase in the IgG1:IgG2 ration in bovine colos- was shown to be mediated by mucosal addressin cell-
trum over that in serum suggested a specific IgG1 transport adhesion molecule-1 (MAdCAM-1) expressed on the
mechanism [23]. mammary vascular endothelium [33], while IgA plasma
By the 1970s, the mechanism for the transport of IgG cell recruitment was found to be facilitated by vascular cell-
into the mammary gland had been elucidated. The IgG adhesion molecule (VCAM-1) [34]. These adhesion mole-
receptor, FcRn, was identified and shown to be present on cules were found to be present in different proportions in
the apical surface of the gut of the suckling rat [24] as well the ruminant mammary gland [35], possibly accounting for
as on the basolateral surface of the secretory epithelial cell some of the differences between species of the immuno-
during colostrogenesis [25]. Immunohistochemical analysis globulin isotypes in colostrum or milk. Recent studies have
showed that FcRn expression coincided with Stage 1 established a role for chemokines in directing immune cells
lactogenesis (the onset of colostrogenesis) and was de- to the mammary gland. Mouse mammary tissue has been
creased during stage 2 lactogenesis (the onset of copious shown to express the CCL28 (MEC) chemokine receptor,
secretion; [26]). which binds to the CCR10 ligand on IgA lymphocytes [36].
The hormonal regulation of immunoglobulin transport Despite these advances, the nature of the stimulus for the
into colostrum and milk has been investigated but remains trafficking of IgA plasma cells from the intestine to the
incompletely described. Smith and co-workers [27] sug- mammary gland, particularly in late-pregnancy, is as yet
gested that changing serum concentrations of estrogen and unknown.
progesterone in late pregnancy exerted a controlling Transport of IgA from immune cells in the mammary
influence on the selective transport of IgG1 to bovine gland into colostrum and milk has been elucidated. Key to
lacteal fluid and thus colostrum formation. However, others this was the identification of the polymeric immunoglobulin
suggested that the rate of IgG1 transfer was a consequence receptor (pIgR), a transmembrane glycoprotein selectively
of mammary gland development [28], which is itself under expressed on mucosal and secretory epithelial basolateral
the control of estrogen and progesterone. Investigation into cell surfaces. Earlier studies had identified a ‘secretory
the role of prolactin in IgG transport showed that in the component’ that was linked to dimeric IgA following its
J Mammary Gland Biol Neoplasia

secretion into mucosal fluids [37]. This secretory compo- immunoglobulins and complement present in milk. By the
nent was later identified as the extracellular domain of 1970s, most components of the complement system were
pIgR. The transport of IgA involved binding to pIgR at the described in human [50] and bovine milk and colostrum
basolateral membrane, passage to the apical membrane then [51].
release into the alveolar lumen by cleavage of the complex, The immune cells in milk may also modulate the
with IgA remaining linked to secretory component [38]. neonatal immune system. This idea was first raised as a
The pIgR protein was found to function as a sacrificial result of observing an increased level of neutrophils in the
receptor, with one molecule of pIgR synthesised for every colostrum of non-nursing mothers in the absence of
molecule of immunoglobulin secreted. The production of infection [52]. Evidence of transfer of tuberculin sensitivity
pIgR appears to limit the amount of IgA that is transported. to suckling infants [53] was used to support this hypothesis,
Transgenic mice overexpressing pIgR in their mammary as was transfer of partial tolerance and graft-versus-host
glands had double the IgA concentration in their milk reactions in rodents [54]. Subsequent studies have con-
compared with non-transgenic mice [39]. The expression of firmed that milk cells can traverse the neonatal intestinal
pIgR was shown to be under endocrine control in some epithelium in a range of species [55, 56]. However, other
tissues [40]. Prolactin and glucocorticoids were shown to studies found no evidence for transfer of cells across the gut
enhance mammary pIgR protein and mRNA levels during [57] or tuberculin-sensitivity via milk [58].
lactation in the sheep [41]. A more recent explanation for modulation of the neonatal
Secretory component was found to be important for the immune system via the cells themselves, is the production of
function of IgA. When bound to IgA, it conferred soluble immune mediators. These “lymphokines” were first
protection from proteolytic degradation in the intestine described in the 1980s and shown to stimulate the immune
[42, 43], and its presence facilitated localization of IgA to cells in the suckling animal [58, 59]. Many studies have
mucus [44]. Free secretory component has antimicrobial since revealed the large range of these proteins (now termed
properties in its own right. It was first isolated from bovine “cytokines”) present in human colostrum or milk. These
milk [45] and subsequent studies have demonstrated that it include IL-1β, IL-6, IL-8, IL-10, IL-12, IL-18, IFN-γ,
binds to fimbrial colonization factors on bacterial surfaces, TNF-α, TGF-β, G-CSF, M-CSF, GM-CSF. These cyto-
thereby reducing their pathogenicity [46]. Free secretory kines are thought to regulate the neonatal immune system
component also binds the cytokine IL-8 thereby modifying in a variety of ways. For example, TGF-β has been
the pro-inflammatory effects of this cytokine [47]. proposed to reduce inflammatory reactions in the gut [60],
to reduce allergy [61] and to stimulate intestinal IgA
production [62]. Cyokines are also present in cow’s milk,
Immunomodulatory Properties of Milk with increased levels during infection (reviewed in [63]).
The advent of recombinant technology enabled the
The immune cells in milk are an important aspect of the production of cytokines such as Il-1, IL-2, IFN-γ and
immunomodulatory activity of milk. The presence of cells GM-CSF which induce higher numbers of neutrophils and
in milk and their association with mammary infection was macrophages when infused into the bovine udder. This
described in the early twentieth century [48, 49]. However, finding has led to the idea that cytokines may be used as
the types of cells, their origin and their role in prevention of immunotherapy for prevention of mastitis in cattle, but to
infection within the gland were debated for many years, date none have been commercialized for routine use.
particularly in non-bovine species. Significant advances in In vitro studies carried out over the last 20 years suggest
immunological analytical techniques eventually led to that the repertoire of immune factors in milk also includes
characterisation of the cell types in milk of humans as well immunomodulatory peptides derived from caseins or whey
as several other species. It is now clear that the cells in proteins. These peptides are receiving much attention as
mammary secretions of all species studied consist of possible sources of ‘natural’ bioactivity with health benefits
neutrophils, macrophages, lymphocytes and a smaller for the consumer (see [64]). Casein peptides have also been
percentage of epithelial cells. In general, macrophages are used to stimulate the innate immune system within the
the major cell population in milk from the healthy lactating mammary gland and prevent infections within the udder of
mammary gland, whereas neutrophils predominate during cows at drying off [65]. However, peptides from the A1
early inflammation. These cells play an important role in variant of β-casein have been proposed to be involved in
signalling the presence of pathogens to the systemic the development of type 1 diabetes, an auto-immune
immune system and thereby mounting a local immune related disease, largely on the basis of epidemiological
response against pathogens. evidence [66].
Neutrophils and macrophages also phagocytose and kill In the 1980s, nucleotides were found in milk and
bacteria directly, and this activity is enhanced by opsonic proposed as potential immune regulators. By the mid
J Mammary Gland Biol Neoplasia

1980s, dietary nucleotide/nucleosides were shown to the reduction in exposure of the infant’s immune system to
modulate cell-mediated immunity and prevent infection in foreign antigens at critical time points may be as important
animals [67]. Since then several infant feeding studies using as the supply of immune factors from milk in the
formula supplemented with nucleotides suggest they subsequent development of allergy in the infant. Much
can influence immune cell development and reduce the further work in these areas will be required to unravel the
incidence of diarrhea. role of immune factors in colostrum and milk and
Long chain poly-unsaturated fatty acids (LC-PUFA) development of mucosal immunity in infants.
such as DHA (docosahexaenoic acids) and EPA (eicosa-
pentaenoic acid) were also identified in the 1980s as
possible candidates for immune modulation. This notion Antimicrobial Proteins in Milk
was based on the observation that the diets of Eskimo
children have a high proportion of fish containing these Initial characterisation of the bactericidal components in
fatty acids, as well as a low incidence of asthma [68]. milk was carried out in the 1920s. In 1922, Alexander
Subsequent studies have shown that infants fed formula Fleming [77] described a bacteriolytic activity which was
supplemented with DHA also have decreased incidence of present in a number of biological fluids, which he named
bronchitis than infants fed un-supplemented formula [69]. lysozyme. Not long after, this activity was also described in
Supplementation of a mother’s diet with LC-PUFA to milk [78]. About this time, what appeared to be a distinct
enhance the immunomodulatory profile of breast milk is antimicrobial action in milk was also described. This
also receiving interest as a means to modify the infant’s activity against streptococci was termed “lactenin” [79].
immune system [70]. Improved techniques for protein analysis in the 1940s
A common feature of the studies over the years is that and 1950s led to the characterisation of these activities. The
human milk is a rich source of many of the above- bactericidal activity of lysozyme was shown to be largely
mentioned immunomodulatory components. The elucida- due to its ability to digest the complex polysaccharide
tion of many of these compounds was driven by the idea component of the bacterial cell wall (reviewed in [80]). The
that breast-feeding prevents gastrointestinal and respiratory isolation of lysozyme from human and cow’s milk was
infectious disease in infants, as initially documented in reported in the 1960s [81, 82], with human milk having by
1930s [71]. This concept has now been broadened to far the greater abundance. Milk was shown to contain at
include potential role of immunomodulatory elements in least two distinct lactenins [83]. One of these was an
development of atopic disease (allergy) in children. Con- oxidase, termed lactoperoxidase [84], which had earlier
centrations of LCPUFA, cytokines, nucleotides and poly- been purified from cow’s milk [85]. Lactoperoxidase was
amines in breast milk have all been associated with subsequently shown to have antimicrobial activity against
development of atopy in infants. In addition, the proportion streptococci in the presence of peroxide and thiocyanate
of neutrophils is significantly higher and macrophages is [86], thereby contributing to the antimicrobial activity of
lower in milk from mothers with an infant suffering from milk.
atopic dermatitis [72]. As human milk cells are a major Other milk antimicrobial activities were also discovered. A
source of some of the cytokines, it is possible that this fraction of cow’s milk with a distinctive red colour was
finding could explain the link between cytokines and described in 1939 [87] and iron-chelating activity in milk was
allergy. In some studies, an infant’s risk of developing noted in 1951 [88]. Later workers characterised the protein
allergy has been linked to the mother, but not the father, responsible and termed it red milk protein, lactotransferrin,
having an allergy [73]. Thus, the association of a specific lactosiderophilin or lactoferrin. Lactoferrin was shown to
cytokine or fatty acid profile in breast milk with subsequent have a bacteriostatic effect against E. coli [89] as well as the
development of atopy in infants may simply relate to the fungus, Candida albicans [90]. The antimicrobial properties
mother’s history of atopy. of lactoferrin were attributed to its ability to sequester iron
Interestingly, one study has suggested a reduction in from the surrounding solution, thereby depriving bacteria of
atopic dermatitis in at risk infants (when at least one parent a mineral necessary for its growth. Xanthine oxidoreductase
has an allergy) after 6 months feeding of a partially activity was first reported in milk, in 1902 [91]. Its
hydrolysed infant formula as opposed to breast milk [74]. antimicrobial activity, when supplied with exogenous sub-
In addition, it has been suggested that prolonged strate, was demonstrated in 1943, and was attributed to the
(>7.5 months) exclusive breast-feeding of high risk infants formation of peroxide [92, 93].
has been associated with increased risk of IgE mediated As a result of these studies, by the mid 1960s, there was
food allergy, asthma and atopy, and atopic dermatitis [75], an appreciation that the defense property of milk was more
although shorter periods of breast-feeding are likely to be complicated than simply the presence of immunoglobulins
protective [76]. These observations support the notion that [94, 95]. Nevertheless, immunoglobulin transfer to the
J Mammary Gland Biol Neoplasia

neonate still dominated most studies on this topic at that action of a range of antimicrobial proteins in milk. Yet, the
time. understanding of host defense in milk was essentially the
Further work in the 1970s provided more detail as to the same as in the 1960s. However, around this time significant
function and biological role of antimicrobial milk proteins. new insights were gained into the nature of innate
Lactoferrin was found to be present in a number of immunity in vertebrates. These included the extensive
additional secretions and fluids that are subject to patho- cross-talk between the innate and acquired immune system,
genic challenge [96], as well as in neutrophils [97], which the first elucidation of the molecular mechanisms for
play an important role in host defense. The level of pathogen recognition and identification of components of
lactoferrin in cow’s milk was shown to rise significantly the signal transduction cascade leading to specific effector
during mastitis [98]. The iron binding properties, predom- responses (reviewed in [117]). Identification of some of the
inance of the apo form of the protein in milk and the iron components of host defense mechanisms in plants, insects
sequestering mechanism for its bacteriostatic effect were all and amphibians led to the discovery of equivalent systems
corroborated [99, 100]. Lactoferrin was also shown to have in mammals, including the β-defensin and cathelicidin
bactericidal as well as bacteriostatic activity, and that it families of cationic antimicrobial peptides (reviewed in
could act on a wider range of microbes than just E. coli [118, 119]). This rapid series of discoveries energized the
[101]. Its antimicrobial activity was found to be due in part field of mammalian innate immunity, and provided a fresh
to alternative mechanisms such as membrane disruption, approach to investigating the host defense properties of
which was attributed to proteolytic cleavage products of milk.
lactoferrin, termed lactoferricins [102]. Lactoferrin has also As a result, additional immune components of milk were
been shown to have activity against a range of viruses, an identified. Members of the β-defensin family were found to
activity that appears largely due to its binding to viral be expressed by mammary epithelial cells with expression
particles, thereby blocking virus entry to the cell (reviewed of their genes induced during mastitis [120, 121]. Members
in [103]. of the β-defensin and cathelicidin families were also found
The bactericidal actions of the enzymes in milk have been in milk and some at elevated levels in colostrum [122, 123].
characterised in greater detail. The substrates for lactoperox- A variant of an acute phase protein, serum amyloid A3, was
idase, hydrogen peroxide and thiocyanate, were shown to be found to be expressed in mammary cells in response to
produced by streptococci and liver detoxification pathways pathogens or pathogen-derived lipoteichoic acid and to be
acting on dietary glucosinolates, respectively [104]. Lacto- present in milk during mastitis [124], suggesting a role for
peroxidase was shown to produce a range of highly reactive this milk protein in host defense.
groups which were thought to react with and disrupt the The repertoire of putative immune factors in milk
bacterial cell membranes (reviewed in [105, 106]). In continues to grow. A member of the RNAse family of
addition to streptococci, this antimicrobial system was also proteins, angiogenin, has been known to be present in milk
found to act against a range of coliforms and Pseudomonas since the 1980s [125]. More recently, a host defense role
species, providing there was a source of peroxide [107, 108]. was claimed for this protein, based on the discovery that
Xanthine oxidoreductase was shown to contribute to the mouse and human angiogenins have antimicrobial activity
lactoperoxidase antimicrobial system by supplying it with [126]. This role in milk is still to be verified, but is
hydrogen peroxide [109]. Further evidence for the host supported by the observation that other members of the
defense role of xanthine oxidoreductase included: its RNase family are found in neutrophils and have antimicro-
production of a range of potentially bactericidal reactive bial as well as antiviral activities [127, 128].
oxygen species [110]; its increased abundance in neutrophils
during infection [111]; and its inhibition being associated
with an increase in microbial activity [112]. Lysozyme was Future Directions
shown to attack the cell walls of Gram positive bacteria by
cleaving the glycosidic bond of N-acetylmuramic acid within It is almost axiomatic that much remains to be discovered
the peptidoglycan molecule [113]. Lysozyme was identified about the innate host defense system in the mammary gland
in the secretory granules of neutrophils [114], associated and its secretions. The potential of the recently developed
with lactoferrin [115]. Proteolytic fragments of the caseins in technologies of genomics, transcriptomics and proteomics
milk were also shown to have antimicrobial activity to shed light on the biology of milk and the mammary
(reviewed in [116]), suggesting that the proteases in milk gland have yet to be fully realised. Gene expression studies
as well as the major milk proteins themselves may also play using microarrays and proteomics published to date have
a role in host defense. revealed a hitherto hidden complexity of the host defense-
By the late 1990s, a considerable body of knowledge associated proteins in milk and the immune response of the
had been accumulated as to the composition and mode of mammary gland [129–134]. These techniques are likely to
J Mammary Gland Biol Neoplasia

result in the identification of yet more components marketed as a product to prevent travellers’ diarrhea. IgA
contributing to the host defense property of milk and has perhaps even more potential in this area, as it has better
colostrum. stability in the GI tract [137]. In the future, milk proteins
A few fundamental questions remain to be answered. with intrinsic bactericidal activity may be alternatives or
The regulation of the milk host defense system is not well supplements to traditional antibiotics, for which there is an
understood. For example, the mechanisms responsible for increasing need [138]. It has also been suggested that the
differences in the composition of colostrum and milk LPS-binding activity of lactoferrin could be used therapeu-
between species and between stages of lactation have yet tically [139]. Other potential uses are in dairying. For
to be described. It is conceivable that these might involve example, antimicrobial proteins have been expressed in
epigenetic mechanisms. Also, the mechanisms by which cow’s milk, either through production of transgenic cattle or
pathogens are recognised by the host defense system is still by transfection of mammary cells in vivo, thereby enhanc-
a relatively unexplored area. Proteins such as Lipopolysac- ing the animal’s resistance to mastitis [140, 141]. It is
charide Binding Protein (LBP) and Bactericidal/Permeability- conceivable that in the future, the level of the endogenous
Increasing Protein (BPI) have a key role in the systemic host defense components in milk could be enhanced by
response to pathogens by binding to pathogen-derived inducing their over-expression through animal management
compounds and presenting them to receptors on immune approaches. Finally, detection of components of the host
cells. It seems likely that an analogous system for pathogen defense in milk could conceivably be used to detect mastitis
recognition exists in milk, but to date this has not been in dairy cows. Similarly, their genes could be used as the
described. basis for genetic selection for resistance to mastitis. Each of
The biological roles of many of the known milk host these applications has particular functional requirements
defense components have still to be fully elucidated. The that will need to be met. Future work will determine to
multifunctional nature of some of these has recently been what extent these potential uses are realised.
suggested, for example the immunomodulatory properties
of lactoferrin and some antimicrobial peptides known to be
present in milk [135, 136]. To date most work on the Acknowledgement The authors wish to acknowledge the efforts of
Claire Miller and the staff at the AgResearch, Ruakura Information
proteins in mammary secretions has concentrated on the Services section in procuring the sometimes obscure original
suppression of pathogens, while other possible functions literature.
have been under-represented in the literature. The immune
system is known to play a role in mammary development
and involution, as well as responding to neoplasia. It will be References
interesting to learn to what extent the proteins in milk
contribute to these processes. Another current question is 1. Kitasato S. Das Verhalten der Cholerabacterien in der Milch. Z
the extent of co-operativity and complementarity between Hyg Infektionskrankh 1889;5:491–6.
the various components, as well as the nature of the 2. Fokker AP. Ueber bacterienvernichtende Eigenschaften der
Milch. Z Hyg Infektionskrankh 1890;9:41–55.
mechanisms by which collectively they suppress the 3. Ehrlich P. Ueber Immunität durch Vererbung und Säugung. Z
viability, growth, or virulence of pathogens of the mamma- Hyg Infektionskr 1892;12:183–203.
ry gland and neonatal GI tract. The possible synergies 4. Isaacs CE. The antimicrobial function of milk lipids. Adv Nutr
between the different proteins have not been thoroughly Res 2001;10:271–85.
5. Newburg DS. Innate immunity and human milk. J Nutr
explored. Rather than consisting simply of immunoglobu- 2005;135(5):1308–12.
lins and a few minor milk proteins with inherent antimi- 6. Ehrlich P, Brieger L. Beiträge zur Kenntnis der Milch immunisirter
crobial properties, it is now perhaps appropriate to view the Thiere. Z Hyg Infektionskr 1893;13:336–46.
defense system in mammary secretions as comprising a 7. Campbell B, Petersen WE. Immune milk—a historical survey.
Dairy Sci Abst 1963;25(9):345–58.
single integrated system. Thus in the future the application 8. Famulener LW. On the transmission of immunity from mother to
of a systems biology approach may be useful. offspring. J Infect Disease 1912;10:332–40.
The host defense proteins in milk have many possible 9. Orcutt ML, Howe PE. The relation between the accumulation of
practical applications. The use of bovine milk extracts as globulins and the appearance of agglutinins in the blood of new-
born calves. J Exp Med 1922;36:291–308.
natural food preservatives and functional food ingredients 10. Smith T, Little RB. The significance of colostrum to the new-
are two potential uses, and these are already beginning to born calf. J Exp Med 1922;36:181–98.
be explored. One example of this is the supplementation of 11. Little RB, Orcutt ML. The transmission of agglutinins of
infant’s formula and other consumer milk-based products Bacillus abortus from cow to calf in the colostrum. J Exp Med
1922;35:161–71.
with lactoferrin. Individual components of milk are already 12. Ratner B, Jackson HC, Gruehl HL. Transmission of protein
being used therapeutically. For example, colostral IgG hypersensitiveness from mother to offspring: I. Critique of
purified from cows immunised with E. coli is being placental permeability. J Immunol 1927;14:249–65.
J Mammary Gland Biol Neoplasia

13. Ratner B, Jackson HC, Gruehl HL. Transmission of protein developing mammary gland in relation to homing receptors and
hypersensitiveness from mother to offspring: II. The role of vascular addressins. J Histochem Cytochem 1999;47(12):
colostrum. J Immunol 1927;14:267–74. 1581–92.
14. Ratner B, Jackson HC, Gruehl HL. Transmission of protein 34. Finke D, Acha-Orbea H. Differential migration of in vivo primed
hypersensitiveness from mother to offspring: III. The rôle of B and T lymphocytes to lymphoid and non-lymphoid organs.
milk. J Immunol 1927;14:275–90. Eur J Immunol 2001;31(9):2603–11.
15. Smith T. The immunological significance of colostrum. I. The 35. Hodgkinson AJ, Carpenter EA, Smith CS, Molan PC, Prosser CG.
relationship between colostrum, serum, and the milk of cows Adhesion molecule expression in the bovine mammary gland. Vet
normal and immunized towards B. coli. J Exp Med Immunol Immunopathol 2007;115(3–4):205–15.
1930;51:473–81. 36. Wilson E, Butcher EC. CCL28 controls immunoglobulin (Ig)A
16. Ingram PL, Lovell R, Wood PC, Aschaffenburg R, Bartlett S, plasma cell accumulation in the lactating mammary gland and
Kon SK, et al. Bacterium coli antibodies in colostrum and their IgA antibody transfer to the neonate. J Exp Med 2004;200
relation to calf survival. J Pathol Bacteriol 1956;72:561–8. (6):805–9.
17. Lascelles AK. A review of the literature on some aspects of 37. Crago SS, Kulhavy R, Prince SJ, Mestecky J. Secretory
immune milk. Dairy Sci Abstr 1963;25(9):359–64. component of epithelial cells is a surface receptor for polymeric
18. Richards CB, Marrack JR. Sheep serum gamma globulin. In: immunoglobulins. J Exp Med 1978;147(6):1832–7.
Peeters H, editor. Protides of the biological fluids bruges. 38. Apodaca G, Katz LA, Mostov KE. Receptor-mediated transcytosis
Amsterdam: Elsevier Science; 1963. p. 154–156. of IgA in MDCK cells is via apical recycling endosomes. J Cell Biol
19. Hanson LA. Comparative immunological studies of the immune 1994;125(1):67–86.
globulins of human milk and of blood serum. Int Arch Allergy 39. de Groot N, Van Kuik-Romeijn P, Lee SH, De Boer HA.
Appl Immunol 1961;18:241–67. Increased immunoglobulin A levels in milk by over-expressing
20. Campbell B, Porter RM, Petersen WE. Plasmacytosis of the the murine polymeric immunoglobulin receptor gene in the
bovine udder during colostrum secretion and experimental mammary gland epithelial cells of transgenic mice. Immunology
cessation of milking. Nature 1950;166(4230):913. 2000;101(2):218–24.
21. Lee CS, Lascelles AK. Antibody-producing cells in antigenically 40. Rosato R, Jammes H, Belair L, Puissant C, Kraehenbuhl JP,
stimulated mammary glands and in the gastro-intestinal tract of Djiane J. Polymeric-Ig receptor gene expression in rabbit
sheep. Aust J Exp Biol Med Sci 1970;48(5):525–35. mammary gland during pregnancy and lactation: evolution and
22. Blakemore F, Garner RJ. The maternal transference of antibodies hormonal regulation. Mol Cell Endocrinol 1995;110(1–2):81–7.
in the bovine. J Comp Pathol 1956;66(4):287–9. 41. Rincheval-Arnold A, Belair L, Djiane J. Developmental expres-
23. Butler JE. Characteristics of bovine immunoglobulins and sion of pIgR gene in sheep mammary gland and hormonal
related molecules. Review of the bovine immunoglobulins. J regulation. J Dairy Res 2002;69(1):13–26.
Dairy Sci 1971;54(9):1315–6. 42. Brown WR, Newcomb RW, Ishizaka K. Proteolytic degradation
24. Jones EA, Waldmann TA. The mechanism of intestinal uptake of exocrine and serum immunoglobulins. J Clin Invest 1970;49
and transcellular transport of IgG in the neonatal rat. J Clin (7):1374–80.
Invest 1972;51(11):2916–27. 43. Shuster J. Pepsin hydrolysis of IgA-delineation of two populations
25. Kemler R, Mossmann H, Strohmaier U, Kickhofen B, Hammer of molecules. Immunochemistry 1971;8(5):405–11.
DK. In vitro studies on the selective binding of IgG from 44. Phalipon A, Cardona A, Kraehenbuhl JP, Edelman L, Sansonetti PJ,
different species to tissue sections of the bovine mammary gland. Corthesy B. Secretory component: a new role in secretory
Eur J Immunol 1975;5(9):603–8. IgA-mediated immune exclusion in vivo. Immunity 2002;17
26. Barrington GM, Besser TE, Gay CC, Davis WC, Reeves JJ, (1):107–15.
McFadden TB, et al. Regulation of the immunoglobulin G1 45. Groves ML, Gordon WG. Isolation of a new glycoprotein-a and
receptor: effect of prolactin on in vivo expression of the bovine a gamma-G-globulin from individual cow milks. Biochemistry
mammary immunoglobulin G1 receptor. J Endocrinol 1999;163 1967;6(8):2388–94.
(1):25–31. 46. de Oliveira IR, de Araujo AN, Bao SN, Giugliano LG. Binding
27. Smith KL, Muir LA, Ferguson LC, Conrad HR. Selective of lactoferrin and free secretory component to enterotoxigenic
transport of IgGl into the mammary gland: role of estrogen and Escherichia coli. FEMS Microbiol Lett 2001;203(1):29–33.
progesterone. J Dairy Sci 1971;54(12):1886–94. 47. Marshall LJ, Perks B, Ferkol T, Shute JK. IL-8 released
28. Lascelles AK, McDowell GH. Localized humoral immunity with constitutively by primary bronchial epithelial cells in culture
particular reference to ruminants. Transplant Rev 1974;19 forms an inactive complex with secretory component. J Immunol
(0):170–208. 2001;167(5):2816–23.
29. Barrington GM, Besser TE, Gay CC, Davis WC, Reeves JJ, 48. Breed RS. The sanitary significance of body cells in milk.. J
McFadden TB. Effect of prolactin on in vitro expression of the Infect Dis. 1914;14:93–9.
bovine mammary immunoglobulin G1 receptor. J Dairy Sci 49. Holm GC. The types of leucocytes in market milk as related to
1997;80(1):94–100. bovine mastitis. J Am Vet Med Assoc 1934;35:735–46.
30. Roux ME, McWilliams M, Phillips-Quagliata JM, Weisz- 50. Nakajima S, Baba AS, Tamura N. Complement system in human
Carrington P, Lamm ME. Origin of IgA-secreting plasma cells colostrum: presence of nine complement components and factors
in the mammary gland. J Exp Med 1977;146(5):1311–22. of alternative pathway in human colostrum. Int Arch Allergy
31. Weisz-Carrington P, Roux ME, Lamm ME. Plasma cells and Appl Immunol 1977;54(5):428–33.
epithelial immunoglobulins in the mouse mammary gland during 51. Reiter B, Brock JH. Inhibition of Escherichia coli by bovine
pregnancy and lactation. J Immunol 1977;119(4):1306–7. colostrum and post-colostral milk. I. Complement-mediated
32. McDermott MR, Bienenstock J. Evidence for a common bactericidal activity of antibodies to a serum susceptible strain
mucosal immunologic system. I. Migration of B immunoblasts of E. coli of the serotype O 111. Immunology 1975;28(1):71–
into intestinal, respiratory, and genital tissues. J Immunol 82.
1979;122(5):1892–8. 52. Smith CW, Goldman AS. The cells of human colostrum .I. In
33. Tanneau GM, Oyant LHS, Chevaleyre CC, Salmon HP. vitro studies of morphology and functions. Pediatr Res 1968;2
Differential recruitment of T- and IgA B-lymphocytes in the (2):103–9.
J Mammary Gland Biol Neoplasia

53. Mohr JA. The possible induction and-or acquisition of cellular 73. Ruiz RG, Kemeny DM, Price JF. Higher risk of infantile atopic
hypersensitivity associated with ingestion of colostrum. J Pediatr dermatitis from maternal atopy than from paternal atopy. Clin
1973;82(6):1062–4. Exp Allergy 1992;22(8):762–6.
54. Beer AE, Billington RE, Head JR. Natural transplantation of 74. Han Y-S, Park H-Y, Ahn K-M, Lee J-S, Choi H-M, Lee S-I.
leukocytes during suckling. Transplant Proc 1975;7:399–402. Short-term effect of partially hydrolysed formula on the
55. Weiler IJ, Hickler W, Sprenger R. Demonstration that milk cells prevention of development of atopic dermatitis in infants at high
invade the suckling neonatal mouse. Am J Reprod Immunol risk. J Korean Med Sci 2003;18:547–51.
1983;4(2):95–8. 75. Saarinen KM, Savilahti E. Infant feeding patterns affect the
56. Sheldrake RF, Husband AJ. Intestinal uptake of intact maternal subsequent immunological features in cow’s milk allergy. Clin
lymphocytes by neonatal rats and lambs. Res Vet Sci 1985;39 Exp Allergy 2000;30(3):400–6.
(1):10–5. 76. Gdalevich M, Mimouni D, David M, Mimouni M. Breast-
57. Miller SC. Failure to demonstrate morphologically the presence feeding and the onset of atopic dermatitis in childhood: a
of colostral or milk cells in the wall of the gastrointestinal tract of systematic review and meta-analysis of prospective studies. J
the suckling neonatal mouse. J Reprod Immunol 1981;3(3):187– Am Acad Dermatol 2001;45(4):520–7.
94. 77. Fleming A. On a remarkable bacteriolytic element found in
58. Keller MA, Kidd RM, Bryson YJ, Turner JL, Carter J. tissues and secretions. Proc Roy Soc Ser Biol Sci 1922;93:306–
Lymphokine production by human milk lymphocytes. Infect 17.
Immun 1981;32(2):632–6. 78. Bordet J, Bordet M. Le pouvoir bacteriolytique du colostrum et
59. Lawton JW, Shortridge KF, Wong RL, Ng MH. Interferon du lait. Compt Rend 1924;179:1109–13.
synthesis by human colostral leucocytes. Arch Dis Child 79. Jones FS, Little RB. The bactericidal properties of cow’s milk. J
1979;54(2):127–30. Exp Med 1927;45:319–35.
60. Donnet-Hughes A, Duc N, Serrant P, Vidal K, Schiffrin EJ. 80. Salton MR. The properties of lysozyme and its action on
Bioactive molecules in milk and their role in health and disease: microorganisms. Bacteriol Rev 1957;21(2):82–100.
the role of transforming growth factor-beta. Immunol Cell Biol 81. Jolles P, Jolles J. Lysozyme from human milk. Nature
2000;78(1):74–9. 1961;192:1187–1188.
61. Penttilla IA. Effects of transforming growth factor-beta and 82. Chandan RC, Shahani KM, Holly RG. Lysozyme content of
formula feeding on systemic immune responses to dietary beta- human milk. Nature 1964;204:76–7.
lactoglobulin in allergy-prone rats. Pediatr Res 2006;59:650–5. 83. Auclair JE. Studies on the antibacterial properties of cow’s milk.
62. Stavnezer J. Regulation of antibody production and class PhD Thesis, University of Reading 1953.
switching by TGF-beta. J Immunol 1995;155(4):1647–51. 84. Wright RC, Tramer J. Factors influencing the activity of cheese
63. Sordillo LM, Shafer-Weaver K, DeRosa D. Immunobiology of starters. The role of milk peroxidase. J Dairy Res 1958;25:104–
the mammary gland. J Dairy Sci 1997;80(8):1851–65. 18.
64. Gauthier SF, Pouliot Y, Saint-Sauveur D. Immunomodulatory 85. Theorell H, Akeson A. Highly purified milk peroxidase. Ark
peptides obtained by the enzymatic hydrolysis of whey proteins. Kemi Mineral Geol 1943;B17(7):1–6.
Int Dairy J 2006;16:1315–1323. 86. Jago GR, Morrison M. Anti-streptococcal activity of lactoper-
65. Silanikove N, Shapiro F, Shamay A, Leitner G. Role of xanthine oxidase III. Proc Soc Exp Biol Med 1962;111:585–8.
oxidase, lactoperoxidase, and NO in the innate immune system 87. Sorensen M, Sorensen SPL. The proteins in whey. C R Trav Lab
of mammary secretion during active involution in dairy cows: Carlsberg 1939;23:55–99.
manipulation with casein hydrolyzates. Free Radic Biol Med 88. Schäfer KH. Elektrophoretische Untersuchengen zum Milch-
2005;38(9):1139–51. weissproblem. Monatsschr Kinderheilkd 1951;99:69.
66. Elliott RB, Harris DP, Hill JP, Bibby NJ, Wasmuth HE. Type I 89. Oram JD, Reiter B. Inhibition of bacteria by lactoferrin and other
(insulin-dependent) diabetes mellitus and cow milk: casein iron-chelating agents. Biochim Biophys Acta 1968;170(2):351–
variant consumption. Diabetologia 1999;42(3):292–6. 65.
67. Yu WH. Scientific rationale and benefits of nucleotide supplemen- 90. Kirkpatrick CH, Green I, Rich RR, Schade AL. Inhibition of
tation of infant formula. J Paediatr Child Health 2002;38:543–9. growth of Candida albicans by iron-unsaturated lactoferrin:
68. Horrobin E. Low prevalences of coronary heart disease relation to host-defense mechanisms in chronic mucocutaneous
(CHD), psoriasis, asthma and rheumatoid arthritis in Eskimos: candidiasis. J Infect Dis 1971;124(6):539–44.
are they caused by high dietary intake of ecosapentaenoic 91. Schardinger F. Ueber das Verhalten der Kuhmilch gegen
acid (EPA), a genetic variation of essential fatty acid (EPA) Methylenblau und seine Verwendung sur Unterscheidung von
metabolism or a combination of both? Med Hypothesis ungekochter und gekochter Milch. Z Unters Nahr Genussm
1987;22:388–96. 1902;5:1113–21.
69. Pastor N, Soler B, Mitmesser SH, Ferguson P, Lifschitz C. 92. Green DE, Pauli R. The antibacterial action of the xanthine
Infants fed docosahexaenoic acid- and arachidonic acid- oxidase system. Proc Soc Exp Biol Med 1943;54:148–50.
supplemented formula have decreased incidence of bronchiolitis/ 93. Lipmann F, Owen CR. The antibacterial effect of enzymatic
bronchitis the first year of life. Clin Pediatr (Phila) 2006;45 xanthine oxidation. Science 1943;98:246–8.
(9):850–5. 94. Gyorgy P, Dhanamitta S, Steers E. Protective effects of human
70. Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, milk in experimental staphylococcus infection. Science
et al. Maternal fish oil supplementation in pregnancy reduces 1962;137:338–40.
interleukin-13 levels in cord blood of infants at high risk of 95. Reiter B, Oram J. Bacterial inhibitors in milk and other
atopy. Clin Exp Allergy 2003;33(4):442–8. biological fluids. Nature 1967;216:328–30.
71. Grulee CG, Sanford HN, Herron PH. Breast and artificial 96. Masson PL, Heremans JF, Dive C. An iron-binding protein
feeding: influences on morbidity and mortality of twenty common to many external secretions. Clin Chim Acta
thousand infants. J Am Med Assoc 1934;103:735–9. 1966;14:735–739.
72. Jarvinen KM, Suomalainen H. Leucocytes in human milk and 97. Masson PL, Heremans JF, Schonne E. Lactoferrin, an iron-
lymphocyte subsets in cow’s milk-allergic infants. Pediatr binding protein in neutrophilic leukocytes. J Exp Med 1969;130
Allergy Immunol 2002;13(4):243–54. (3):643–58.
J Mammary Gland Biol Neoplasia

98. Harmon RJ, Schanbacher FL, Ferguson LC, Smith KL. Concen- 120. Goldammer T, Zerbe H, Molenaar A, Schuberth HJ, Brunner
tration of lactoferrin in milk of normal lactating cows and RM, Kata SR, et al. Mastitis increases mammary mRNA
changes occurring during mastitis. Am J Vet Res 1975;36 abundance of beta-defensin 5, toll-like-receptor 2 (TLR2), and
(7):1001–7. TLR4 but not TLR9 in cattle. Clin Diagn Lab Immunol 2004;11
99. Masson PL, Heremans JF. Metal-combining properties of human (1):174–85.
lactoferrin (red milk protein). 1. The involvement of bicarbonate 121. Swanson K, Gorodetsky S, Good L, Davis S, Musgrave D,
in the reaction. Eur J Biochem 1968;6(4):579–84. Stelwagen K, et al. Expression of a beta-defensin mRNA, lingual
100. Goldsmith SJ, Eitenmiller RR, Barnhart HM, Toledo RT, Rao antimicrobial peptide, in bovine mammary epithelial tissue is
VN. Unsaturated iron-binding capacity of human milk. J Food induced by mastitis. Infect Immun 2004;72(12):7311–4.
Sci 1982;47:1298–304. 122. Armogida SA, Yannaras NM, Melton AL, Srivastava MD.
101. Arnold RR, Brewer M, Gauthier JJ. Bactericidal activity of Identification and quantification of innate immune system
human lactoferrin: sensitivity of a variety of microorganisms. mediators in human breast milk. Allergy Asthma Proc 2004;25
Infect Immun 1980;28(3):893–8. (5):297–304.
102. Tomita M, Bellamy W, Takase M, Yamauchi K, Wakabayashi H, 123. Murakami M, Dorschner RA, Stern LJ, Lin KH, Gallo RL.
Kawase K. Potent antibacterial peptides generated by pepsin Expression and secretion of cathelicidin antimicrobial peptides in
digestion of bovine lactoferrin. J Dairy Sci 1991;74(12):4137– murine mammary glands and human milk. Pediatr Res 2005;57
42. (1):10–5.
103. van der Strate BW, Beljaars L, Molema G, Harmsen MC, Meijer 124. McDonald TL, Larson MA, Mack DR, Weber A. Elevated
DK. Antiviral activities of lactoferrin. Antiviral Res 2001;52 extrahepatic expression and secretion of mammary-associated
(3):225–39. serum amyloid A 3 (M-SAA3) into colostrum. Vet Immunol
104. Reiter B. The lactoperoxidase-thiocyanate-hydrogen peroxide Immunopathol 2001;83(3–4):203–11.
antibacterium system. Ciba Found Symp 1978;65:285–94. 125. Maes P, Damart D, Rommens C, Montreuil J, Spik G, Tartar A.
105. de Wit JN, Hooydonk ACM. Structure, functions and applications The complete amino acid sequence of bovine milk angiogenin.
of lactoperoxidase in natural antimicrobial systems. Neth Milk FEBS Lett 1988;241(1–2):41–5.
Dairy J 1996;50:227–44. 126. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins:
106. Kussendrager KD, van Hooijdonk AC. Lactoperoxidase: physico- a new class of microbicidal proteins involved in innate immunity.
chemical properties, occurrence, mechanism of action and Nat Immunol 2003;4(3):269–73.
applications. Br J Nutr. 2000;84(Suppl 1):S19–S25. 127. Egesten A, Dyer KD, Batten D, Domachowske JB, Rosenberg HF.
107. Bjorck L, Rosen C, Marshall V, Reiter B. Antibacterial activity Ribonucleases and host defense: identification, localization and
of the lactoperoxidase system in milk against pseudomonads and gene expression in adherent monocytes in vitro. Biochim Biophys
other gram-negative bacteria. Appl Microbiol 1975;30(2):199– Acta 1997;1358(3):255–60.
204. 128. Rosenberg HF, Domachowske JB. Eosinophils, eosinophil
108. Reiter B, Marshall VM, Bjorck L, Rosen CG. Nonspecific ribonucleases, and their role in host defense against respiratory
bactericidal activity of the lactoperoxidases-thiocyanate-hydrogen virus pathogens. J Leukoc Biol 2001;70(5):691–8.
peroxide system of milk against Escherichia coli and some gram- 129. Donaldson L, Vuocolo T, Gray C, Strandberg Y, Reverter A,
negative pathogens. Infect Immun 1976;13(3):800–7. McWilliam S, et al. Construction and validation of a bovine
109. Bjorck L, Claesson O. Xanthine oxidase as a source of hydrogen innate immune microarray. BMC Genomics 2005;6:135.
peroxide for the lactoperoxidase system in milk. J Dairy Sci 130. Swanson KM, Henderson HV, Farr VC, Davis SR, Oden K,
1979;62:1211–5. Stelwagen K, et al. The use of microarrays to investigate gene
110. Hunt J, Massey V. Purification and properties of milk xanthine regulation in the bovine mammary gland during Streptococcus
dehydrogenase. J Biol Chem 1992;267(30):21479–85. uberis mastitis. Proc NZ Soc Anim Prod 2004;64:14–6.
111. Tubaro E, Lotti B, Santiangeli C, Cavallo G. Xanthine oxidase 131. Stein T, Morris JS, Davies CR, Weber-Hall SJ, Duffy MA, Heath
increase in polymorphonuclear leucocytes and macrophages in VJ, et al. Involution of the mouse mammary gland is associated
mice in three pathological situations. Biochem Pharmacol with an immune cascade and an acute-phase response, involving
1980;29(3):1945–8. LBP, CD14 and STAT3. Breast Cancer Res 2004;6(2):R75–R91.
112. Bungener W. Influence of allopurinol on the multiplication of 132. Clarkson RW, Wayland MT, Lee J, Freeman T, Watson CJ. Gene
rodent malaria parasites. Tropenmed Parasitol 1974;25(3):309– expression profiling of mammary gland development reveals
12. putative roles for death receptors and immune mediators in post-
113. Chipman DM, Sharon N. Mechanism of lysozyme action. lactational regression. Breast Cancer Res 2004;6(2):R92–R109.
Science 1969;165(892):454–65. 133. Hogarth CJ, Fitzpatrick JL, Nolan AM, Young FJ, Pitt A,
114. Cohn ZA, Hirsch JG. The isolation and properties of the specific Eckersall PD. Differential protein composition of bovine whey: a
cytoplasmic granules of rabbit polymorphonuclear leucocytes. J comparison of whey from healthy animals and from those with
Exp Med 1960;112:983–1004. clinical mastitis. Proteomics 2004;4(7):2094–100.
115. Leffell MS, Spitznagel JK. Association of lactoferrin with 134. Smolenski G, Haines S, Kwan FY, Bond J, Farr V, Davis SR,
lysozyme in granules of human polymorphonuclear leukocytes. et al. Characterisation of host defence proteins in milk using a
Infect Immun 1972;6(5):761–5. proteomic approach. J Proteome Res 2007;6(1):207–15.
116. Lahov E, Regelson W. Antibacterial and immunostimulating 135. Takakura N, Wakabayashi H, Yamauchi K, Takase M. Influences
casein-derived substances from milk: casecidin, isracidin peptides. of orally administered lactoferrin on IFN-gamma and IL-10
Food Chem Toxicol 1996;34(1):131–45. production by intestinal intraepithelial lymphocytes and mesen-
117. Medzhitov R, Janeway CA Jr. Innate immunity: impact on the teric lymph-node cells. Biochem Cell Biol 2006;84(3):363–8.
adaptive immune response. Curr Opin Immunol 1997;9(1): 136. Bowdish DM, Davidson DJ, Hancock RE. Immunomodulatory
4–9. properties of defensins and cathelicidins. Curr Top Microbiol
118. Lehrer RI, Ganz T. Defensins of vertebrate animals. Curr Opin Immunol 2006;306:27–66.
Immunol 2002;14(1):96–102. 137. Hodgkinson AJ, Cannon RD, Holmes AR, Fischer FJ, Willix-
119. Zanetti M. Cathelicidins, multifunctional peptides of the innate Payne DJ. Production from dairy cows of semi-industrial
immunity. J Leukoc Biol 2004;75(1):39–48. quantities of milk-protein concentrate (MPC) containing effica-
J Mammary Gland Biol Neoplasia

cious anti-Candida albicans IgA antibodies. J Dairy Res 2007;74 140. Kerr DE, Plaut K, Bramley AJ, Williamson CM, Lax AJ, Moore
(3):269–75. K, et al. Lysostaphin expression in mammary glands confers
138. Finlay BB, Hancock RE. Can innate immunity be enhanced to protection against staphylococcal infection in transgenic mice.
treat microbial infections? Nat Rev Microbiol 2004;2(6):497–504. Nat Biotechnol 2001;19(1):66–70.
139. Caccavo D, Pellegrino NM, Altamura M, Rigon A, Amati L, 141. Sun H-C, Xue F-M, Qian K, Fang H-X, Qiu H-L, Zhang X-Y,
Amoroso A, et al. Antimicrobial and immunoregulatory func- et al. Intramammary expression and therapeutic effect of a
tions of lactoferrin and its potential therapeutic application. J human lysozyme-expressing vector for treating bovine mastitis. J
Endotoxin Res 2002;8(6):403–17. Zhejiang Univ Science B 2006;7:324–330.

You might also like